Nicole Juffermans: Comparing the Effect of Plasma Versus Clear Fluids on Intravascular Volume
Nicole Juffermans, Intensivist and Professor of Translational Intensive Care Medicine at Erasmus Medical Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“It is often said that a decrease in Hb may be due to hemodilution of concomittantly infused volume.
We compared the effect of plasma versus clear fluids on the ability to expand circulating blood volume:
Clear fluids do not cause a drop in Hb level, probably because they are lost in the interstitium early.
In contrast, plasma does cause a drop in Hb, due to augmentation of cardiac output, translating into improved tissue perfusion.”
Title: The effect of plasma versus crystalloids on intravascular volume, tissue perfusion and tissue oxygenation: a randomized controlled trial in a human endotoxemia model
Authors: Bashar Hilderink, Daan van den Brink, Derek Kleinveld, Robert Klanderman, Philip Spinella, Nicole Juffermans
Read the Full Article on Critical Care.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 7, 2026, 14:55Alfadil Haroon: New Genetic Insights into Bone Marrow Failure Syndromes
-
Mar 7, 2026, 14:48Shaine Morris: Save the Date for the Texas Children’s Hospital Second Pediatric Aortopathy Symposium
-
Mar 7, 2026, 14:46Ahmad Hazri Mohamed Aris: Strengthening Bleeding Disorders Care Through WFH PACT 2026–2030
-
Mar 7, 2026, 14:42Megan Adediran: When Should Heavy Bleeding Stop Being Called Normal?
-
Mar 7, 2026, 14:41Heghine Khachatryan: Best-Practice Recommendations for Implementing Shared Decision-Making in Hemophilia Care
-
Mar 7, 2026, 14:37Julie Kennedy Lesch: Driving Progress for People Living with Sickle Cell Disease
-
Mar 6, 2026, 16:51Priya Reehal: Highlighting The Central Role of Nurses in Cardio-Oncology
-
Mar 6, 2026, 16:50Adrian Gottschlich: Blinatumomab Shows Remarkable Response in Multi-Refractory ITP and APS
-
Mar 6, 2026, 16:18Laila Shalabi: Clopidogrel, Aspirin, and the Role of PPIs in Coronary Artery Disease